Abstract
As the most routinely used ultrasound contrast agent (UCA), ultrasound-responsive microbubbles can be developed as a multifunctional platform by loading multiple functional components into their shells or core domains. Additionally, such microbubbles can be coupled with targeting ligands for selective contrasting of the areas of disease and be selectively destroyed in the ultrasound field. Therefore, multifunctional ultrasound contrast agents hold great promise for contrast enhancement, molecular imaging, multimodal imaging, and drug/gene delivery with the opportunity for rational therapeutic dosing, as well as integrated diagnostics and therapeutics. As a result, multifunctional UCAs are highly advantageous to (pre)clinical implementation, not only because they could help visualize drug distribution and drug release at the target site and understand various essential aspects of the drug delivery process but also because they could contribute to the optimization of strategies relying on triggered drug release, to the prediction and real-time monitoring of therapeutic responses, and hence to the development of more efficient and less toxic treatment regimens for individual patients. This current review describes a biomedical engineering design process in which state-of-the-art UCA platforms can be designed to synergize ultrasonic imaging with other noninvasive imaging modalities, as well as to integrate imaging (diagnosis) and therapy. Multimodality imaging based on UCAs may create an exciting clinical opportunity and flexibility unachievable with either modality alone. Multimodal molecular imaging-guided targeted drug delivery and therapy will likely change the future of clinical medicine as these technologies continue to mature.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Park JI, Jagadeesan D, Williams R et al (2010) Microbubbles loaded with nanoparticles: a route to multiple imaging modalities. ACS Nano 4:6579–6586
Stride E, Edirisinghe M (2008) Novel microbubble preparation technologies. Soft Matter 4:2350–2359
Zhang Y, Yang Y, Cai W (2011) Multimodality imaging of integrin αvβ3 expression. Theranostics 1:135
Kiessling F, Gaetjens J, Palmowski M (2011) Application of molecular ultrasound for imaging integrin expression. Theranostics 1:127
Feinstein SB, Ten Cate FJ, Zwehl W et al (1984) Two-dimensional contrast echocardiography. I In vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol 3:14–20
El‐Sherif DM, Wheatley MA (2003) Development of a novel method for synthesis of a polymeric ultrasound contrast agent. J Biomed Mater Res A 66:347–355
Straub JA, Chickering DE, Church CC et al (2005) Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J Control Release 108:21–32
Leong-Poi H, Christiansen J, Heppner P et al (2005) Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation 111:3248–3254
Rychak JJ, Lindner JR, Ley K et al (2006) Deformable gas-filled microbubbles targeted to P-selectin. J Control Release 114:288–299
Basude R, Duckworth JW, Wheatley MA (2000) Influence of environmental conditions on a new surfactant-based contrast agent: ST68. Ultrasound Med Biol 26:621–628
Takeuchi S, Sato T, Kawashima N (2002) Nonlinear response of microbubbles coated with surfactant membrane developed as ultrasound contrast agent – experimental study and numerical calculations. Colloid Surf B 24:207–216
Klibanov AL (2009) Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging. Med Biol Eng Comput 47:875–882
Bartolotta TV, Quaia E (2005) Contrast media in ultrasonography: basic principles and clinical applications. Springer Science & Business Media, Heidelberg
Miller DL, Li P, Dou C et al (2005) Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats 1. Radiology 237:137–143
Miller DL (2007) Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation. Prog Biophys Mol Biol 93:314–330
Brinker J (2002) What every cardiologist should know about intravascular contrast. Rev Cardiovasc Med 4:S19–S27
Vancraeynest D, Havaux X, Pouleur AC et al (2006) Myocardial delivery of colloid nanoparticles using ultrasound-targeted microbubble destruction. Eur Heart J 27:237–245
Pislaru SV, Pislaru C, Kinnick RR et al (2003) Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities. Eur Heart J 24:1690–1698
Guo C, Jin Y, Dai Z (2014) Multifunctional ultrasound contrast agents for imaging guided photothermal therapy. Bioconjug Chem 25:840–854
Klibanov AL (2002) Ultrasound contrast agents: development of the field and current status. In: Contrast agents II. Springer, Heidelberg
Perkins A, Frier M, Hindle A et al (1997) Human biodistribution of an ultrasound contrast agent (quantison) by radiolabelling and gamma scintigraphy. Br J Radiol 70:603–611
Unger EC, McCreery TP, Sweitzer RH et al (1998) Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 33:886–892
Church CC (1995) The effects of an elastic solid surface layer on the radial pulsations of gas bubbles. J Acoust Soc Am 97:1510–1521
Hvattum E, Normann PT, Oulie I et al (2001) Determination of perfluorobutane in rat blood by automatic headspace capillary gas chromatography and selected ion monitoring mass spectrometry. J Pharm Biomed Anal 24:487–494
FRITZ TA, UNGER EC, SUTHERLAND G et al (1997) Phase I clinical trials of MRX-115: a new ultrasound contrast agent. Invest Radiol 32:735–740
Xing Z, Ke H, Wang J et al (2010) Novel ultrasound contrast agent based on microbubbles generated from surfactant mixtures of span 60 and polyoxyethylene 40 stearate. Acta Biomater 6:3542–3549
Tachibana K (1992) Enhancement of fibrinolysis with ultrasound energy. J Vasc Interv Radiol 3:299–303
Price RJ, Skyba DM, Kaul S et al (1998) Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 98:1264–1267
Lawrie A, Brisken A, Francis S et al (2000) Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 7:2023–2027
Porter TR, Iversen PL, Li S et al (1996) Interaction of diagnostic ultrasound with synthetic oligonucleotide-labeled perfluorocarbon-exposed sonicated dextrose albumin microbubbles. J Ultrasound Med 15:577–584
Lanza GM, Trousil RL, Wallace KD et al (1998) In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J Acoust Soc Am 104:3665–3672
Hall CS, Marsh JN, Scott MJ et al (2000) Time evolution of enhanced ultrasonic reflection using a fibrin-targeted nanoparticulate contrast agent. J Acoust Soc Am 108:3049–3057
Kim DH, Klibanov AL, Needham D (2000) The influence of tiered layers of surface-grafted poly (ethylene glycol) on receptor-ligand-mediated adhesion between phospholipid monolayer-stabilized microbubbles and coated glass beads. Langmuir 16:2808–2817
Lindner JR, Song J, Christiansen J et al (2001) Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 104:2107–2112
Wu Y, Unger EC, McCREERY TP et al (1998) Binding and lysing of blood clots using MRX-408. Invest Radiol 33:880–885
Allen T, Williamson P, Schlegel RA (1988) Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc Natl Acad Sci U S A 85:8067–8071
Fadok VA, Voelker DR, Campbell PA et al (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207–2216
Lindner JR, Coggins MP, Kaul S et al (2000) Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin-and complement-mediated adherence to activated leukocytes. Circulation 101:668–675
Lindner JR, Dayton PA, Coggins MP et al (2000) Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 102:531–538
Ferrara KW, Merritt CR, Burns PN et al (2000) Evaluation of tumor angiogenesis with US: imaging, doppler, and contrast agents. Acad Radiol 7:824–839
Clay CS, Medwin H (1977) Acoustical oceanography: principles and applications. Wiley, New York
Soetanto K, Chan M (2000) Fundamental studies on contrast images from different-sized microbubbles: analytical and experimental studies. Ultrasound Med Biol 26:81–91
Tweedle MF (2009) Peptide-targeted diagnostics and radiotherapeutics. Acc Chem Res 42:958–968
Villanueva FS, Jankowski RJ, Klibanov S et al (1998) Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 98:1–5
Weller GE, Lu E, Csikari MM et al (2003) Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation 108:218–224
Stieger SM, Dayton PA, Borden MA et al (2008) Imaging of angiogenesis using cadence™ contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging 3:9–18
Lanza GM, Wickline SA (2003) Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr Prob Cardiol 28:625–653
Kaufmann BA, Carr CL, Belcik JT et al (2010) Molecular imaging of the initial inflammatory response in atherosclerosis implications for early detection of disease. Arterioscler Thromb Vasc Biol 30:54–59
Unger EC, McCreery TP, Sweitzer RH et al (1998) In vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol 81:58G–61G
Alonso A, Della Martina A, Stroick M et al (2007) Molecular imaging of human thrombus with novel Abciximab immunobubbles and ultrasound. Stroke 38:1508–1514
Pochon S, Tardy I, Bussat P et al (2010) BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 45:89–95
Pysz MA, Foygel K, Rosenberg J et al (2010) Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55) 1. Radiology 256:519–527
Kaneko OF, Willmann JK (2012) Ultrasound for molecular imaging and therapy in cancer. Quant Imaging Med Surg 2:87
Ferrante E, Pickard J, Rychak J et al (2009) Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release 140:100–107
Willmann JK, Lutz AM, Paulmurugan R et al (2008) Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo 1. Radiology 248:936–944
Warram JM, Sorace AG, Saini R et al (2011) A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature. J Ultrasound Med 30:921–931
Deshpande N, Needles A, Willmann JK (2010) Molecular ultrasound imaging: current status and future directions. Clin Radiol 65:567–581
Yin T, Wang P, Zheng R et al (2012) Nanobubbles for enhanced ultrasound imaging of tumors. Int J Nanomedicine 7:895
Rapoport N, Gao Z, Kennedy A (2007) Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 99:1095–1106
Lanza GM, Wallace KD, Fischer SE et al (1997) High-frequency ultrasonic detection of thrombi with a targeted contrast system. Ultrasound Med Biol 23:863–870
Lanza GM, Wallace KD, Scott MJ et al (1996) A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 94:3334–3340
Villanueva FS, Lu E, Bowry S et al (2007) Myocardial ischemic memory imaging with molecular echocardiography. Circulation 115:345–352
Villanueva FS, Wagner WR (2008) Ultrasound molecular imaging of cardiovascular disease. Nat Clin Pract Cardiovasc Med 5:S26–S32
Schumann PA, Christiansen JP, Quigley RM et al (2002) Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol 37:587–593
Louie A (2010) Multimodality imaging probes: design and challenges. Chem Rev 110:3146–3195
Pisani E, Tsapis N, Galaz B et al (2008) Perfluorooctyl bromide polymeric capsules as dual contrast agents for ultrasonography and magnetic resonance imaging. Adv Funct Mater 18:2963–2971
An L, Hu H, Du J et al (2014) Paramagnetic hollow silica nanospheres for in vivo targeted ultrasound and magnetic resonance imaging. Biomaterials 35:5381–5392
Yang F, Li Y, Chen Z et al (2009) Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Biomaterials 30:3882–3890
Liu Z, Lammers T, Ehling J et al (2011) Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 32:6155–6163
Nguyen QT, Olson ES, Aguilera TA et al (2010) Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci U S A 107:4317–4322
Gray DC, Kim EM, Cotero VE et al (2012) Dual-mode laparoscopic fluorescence image-guided surgery using a single camera. Biomed Opt Express 3:1880–1890
Tichauer KM, Samkoe KS, Sexton KJ et al (2012) Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging. J Biomed Opt 17:0660011–06600110
Zhu Q, Conant E, Chance B (2000) Optical imaging as an adjunct to sonograph in differentiating benign from malignant breast lesions. J Biomed Opt 5:229–236
Ke H, Xing Z, Zhao B et al (2009) Quantum-dot-modified microbubbles with bi-mode imaging capabilities. Nanotechnology 20:425105
Hernot S, Klibanov AL (2008) Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 60:1153–1166
Mai L, Yao A, Li J et al (2013) Cyanine 5.5 conjugated nanobubbles as a tumor selective contrast agent for dual ultrasound-fluorescence imaging in a mouse model. Plos One 8, e61224
Zha Z, Wang J, Zhang S et al (2014) Engineering of perfluorooctylbromide polypyrrole nano-/microcapsules for simultaneous contrast enhanced ultrasound imaging and photothermal treatment of cancer. Biomaterials 35:287–293
Zha Z, Deng Z, Li Y et al (2013) Biocompatible polypyrrole nanoparticles as a novel organic photoacoustic contrast agent for deep tissue imaging. Nanoscale 5:4462–4467
Huynh E, Lovell JF, Helfield BL et al (2012) Porphyrin shell microbubbles with intrinsic ultrasound and photoacoustic properties. J Am Chem Soc 134:16464–16467
Wilson K, Homan K, Emelianov S (2012) Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging. Nat Commun 3:618
Hannah AS, VanderLaan D, Chen YS et al (2014) Photoacoustic and ultrasound imaging using dual contrast perfluorocarbon nanodroplets triggered by laser pulses at 1064 nm. Biomed Opt Express 5:3042–3052
Hannah A, Luke G, Wilson K et al (2013) Indocyanine green-loaded photoacoustic nanodroplets: dual contrast nanoconstructs for enhanced photoacoustic and ultrasound imaging. ACS Nano 8:250–259
Huynh E, Jin CS, Wilson BC et al (2014) Aggregate enhanced trimodal porphyrin shell microbubbles for ultrasound, photoacoustic, and fluorescence imaging. Bioconjug Chem 25:796–801
Huynh E, Leung BYC, Helfield BL et al (2015) In situ conversion of porphyrin microbubbles to nanoparticles for multimodality imaging. Nat Nanotechnol 10:325–332
Miao ZH, Guo C, ZL L (2015) Fabrication of a multimodal microbubble platform for MR, US and fluorescence imaging application. J Nanosci Nanotechnol doi:10.1166/jnn.2015.10952
Wang X, Chen H, Chen Y et al (2012) Perfluorohexane‐encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient High Intensity Focused Ultrasound (HIFU). Adv Mater 24:785–791
Wang X, Chen H, Zhang K et al (2014) An intelligent nanotheranostic agent for targeting, redox-responsive ultrasound imaging, and imaging-guided high-intensity focused ultrasound synergistic therapy. Small 10:1403–1411
Zhou Y, Wang Z, Chen Y et al (2013) Microbubbles from gas-generating perfluorohexane nanoemulsions for targeted temperature-sensitive ultrasonography and synergistic HIFU ablation of tumors. Adv Mater 25:4123–4130
Sun Y, Zheng Y, Ran H et al (2012) Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation. Biomaterials 33:5854–5864
Zhang X, Zheng Y, Wang Z et al (2014) Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and synergistic targeted therapy of residual tumor during HIFU ablation. Biomaterials 35:5148–5161
Chen J, Glaus C, Laforest R et al (2010) Gold nanocages as photothermal transducers for cancer treatment. Small 6:811–817
Jang B, Park JY, Tung CH et al (2011) Gold nanorod – photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano 5:1086–1094
Choi WI, Kim J-Y, Kang C et al (2011) Tumor regression in vivo by photothermal therapy based on gold-nanorod-loaded, functional nanocarriers. ACS Nano 5:1995–2003
Moon HK, Lee SH, Choi HC (2009) In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 3:3707–3713
Zhou F, Xing D, Ou Z et al (2009) Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes. J Biomed Opt 14:021009
Yang K, Zhang S, Zhang G et al (2010) Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 10:3318–3323
Li Y, Lu W, Huang Q et al (2010) Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine 5:1161–1171
Fu G, Liu W, Feng S et al (2012) Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy. Chem Commun 48:11567–11569
Zha Z, Yue X, Ren Q et al (2013) Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells. Adv Mater 25:777–782
Cosgrove D (2006) Ultrasound contrast agents: an overview. Eur J Radiol 60:324–330
Sandhu IS, Bhutani MS (2002) Gastrointestinal endoscopic ultrasonography. Med Clin North Am 86:1289–1317
Varghese T, Zagzebski J, Chen Q et al (2002) Ultrasound monitoring of temperature change during radiofrequency ablation: preliminary in-vivo results. Ultrasound Med Biol 28:321–329
El‐Sherif DM, Lathia JD, Le NT et al (2004) Ultrasound degradation of novel polymer contrast agents. J Biomed Mater Res A 68:71–78
Hirsch LR, Stafford R, Bankson J et al (2003) Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A 100:13549–13554
Yang J, Lee J, Kang J et al (2009) Smart drug‐loaded polymer gold nanoshells for systemic and localized therapy of human epithelial cancer. Adv Mater 21:4339–4342
Ke HT, Wang JR, Dai ZF et al (2011) Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy. Angew Chem Int Ed Engl 50:3017–3021
Ke HT, Wang JR, Tong S et al (2014) Gold nanoshelled liquid perfluorocarbon magnetic nanocapsules: a nanotheranostic platform for bimodal ultrasound/magnetic resonance imaging guided photothermal tumor ablation. Theranostics 4:12–23
Bendayan M, Hayat M (1989) Colloidal gold: principles, methods, and applications. Academic Press, San Diego
Geso M (2007) Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 80:64–65
Jin Y, Wang J, Ke H et al (2013) Graphene oxide modified PLA microcapsules containing gold nanoparticles for ultrasonic/CT bimodal imaging guided photothermal tumor therapy. Biomaterials 34:4794–4802
Li XD, Liang XL, Yue XL et al (2014) Imaging guided photothermal therapy using iron oxide loaded poly (lactic acid) microcapsules coated with graphene oxide. J Mater Chem B 2014(2):217–223
Zhang G, Yang Z, Lu W et al (2009) Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 30:1928–1936
Zha Z, Wang S, Zhang S et al (2013) Targeted delivery of CuS nanoparticles through ultrasound image-guided microbubble destruction for efficient photothermal therapy. Nanoscale 5:3216–3219
Jia X, Cai X, Chen Y et al (2015) Perfluoropentane-encapsulated hollow mesoporous Prussian blue nanocubes for activated ultrasound imaging and photothermal therapy of cancer. ACS Appl Mater Interfaces 7:4579–4588
Wang Y, Liao A, Chen J et al (2012) Photoacoustic/ultrasound dual-modality contrast agent and its application to thermotherapy. J Biomed Opt 17:0450011–0450018
Cai X, Jia X, Gao W et al (2015) A versatile nanotheranostic agent for efficient dual-mode imaging guided synergistic chemo-thermal tumor therapy. Adv Funct Mater 25:2520–2529
Sharifi S, Behzadi S, Laurent S et al (2012) Toxicity of nanomaterials. Chem Soc Rev 41:2323–2343
Ma Y, Dai Z, Zha Z et al (2011) Selective antileukemia effect of stabilized nanohybrid vesicles based on cholesteryl succinyl silane. Biomaterials 32:9300–9307
Ramanaviciene A, Kausaite A, Tautkus S et al (2007) Biocompatibility of polypyrrole particles: an in‐vivo study in mice. J Pharm Pharmacol 59:311–315
Jang KS, Ko HC, Moon B et al (2005) Observation of photoluminescence in polypyrrole micelles. Synth Met 150:127–131
Bai MY, Cheng YJ, Wickline SA et al (2009) Colloidal hollow spheres of conducting polymers with smooth surface and uniform, controllable sizes. Small 5:1747–1752
Zha ZB, Wang JR, Qu EZ et al (2013) Polypyrrole hollow microspheres as echogenic photothermal agent for ultrasound imaging guided tumor ablation. Sci Rep 3
Fan CH, Ting CY, Lin HJ et al (2013) SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery. Biomaterials 34:3706–3715
Wu H, Shi H, Zhang H et al (2014) Prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery. Biomaterials 35:5369–5380
Gerweck LE, Seetharaman K (1996) Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 56:1194–1198
Min KH, Min HS, Lee HJ et al (2015) pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers. ACS Nano 9:134–145
Park JH, Gu L, Von Maltzahn G et al (2009) Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater 8:331–336
Poland CA, Duffin R, Kinloch I et al (2008) Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3:423–428
Yang P, Li D, Jin S et al (2014) Stimuli-responsive biodegradable poly (methacrylic acid) based nanocapsules for ultrasound traced and triggered drug delivery system. Biomaterials 3:2079–2088
Kripfgans OD, Fowlkes JB, Miller DL et al (2000) Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol 26:1177–1189
Couture O, Bevan PD, Cherin E et al (2006) A model for reflectivity enhancement due to surface bound submicrometer particles. Ultrasound Med Biol 32:1247–1255
Singh R, Husseini GA, Pitt WG (2012) Phase transitions of nanoemulsions using ultrasound: experimental observations. Ultrason Sonochem 19:1120–1125
Strohm E, Rui M, Gorelikov I et al (2011) Vaporization of perfluorocarbon droplets using optical irradiation. Biomed Opt Express 2:1432–1442
Strohm E, Rui M, Gorelikov I et al (2011) Optical droplet vaporization of micron-sized perfluorocarbon droplets and their photoacoustic detection. SPIE BiOS. International Society for Optics and Photonics,78993H-78993H-7
Wei CW, Lombardo M, Larson-Smith K et al (2014) Nonlinear contrast enhancement in photoacoustic molecular imaging with gold nanosphere encapsulated nanoemulsions. Appl Phys Lett 104:033701
Jian J, Liu C, Gong Y et al (2014) India ink incorporated multifunctional phase-transition nanodroplets for photoacoustic/ultrasound dual-modality imaging and photoacoustic effect based tumor therapy. Theranostics 4:1026
Sun Y, Wang Y, Niu C et al (2014) Laser-activatible PLGA microparticles for image-guided cancer therapy in vivo. Adv Funct Mater 24:7674–7680
Acknowledgments
This work was financially supported by National Natural Science Foundation for Distinguished Young Scholars (Grant No. 81225011), State Key Program of National Natural Science of China (Grant No. 81230036), and National Natural Science Foundation of China (Grant No. 21273014 and No. 81201186).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Gao, C., Dai, Z. (2016). Multifunctional Ultrasound Contrast Agents Integrating Targeted Imaging and Therapy. In: Dai, Z. (eds) Advances in Nanotheranostics II. Springer Series in Biomaterials Science and Engineering, vol 7. Springer, Singapore. https://doi.org/10.1007/978-981-10-0063-8_4
Download citation
DOI: https://doi.org/10.1007/978-981-10-0063-8_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-0061-4
Online ISBN: 978-981-10-0063-8
eBook Packages: EngineeringEngineering (R0)